Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Center-Sophia Children's Hospital, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands.
ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus Medical Center Sophia Children's Hospital, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands.
J Autism Dev Disord. 2018 Jul;48(7):2278-2285. doi: 10.1007/s10803-018-3478-0.
In a non-selected sample of children with Neurofibromatosis type 1 (NF1) the prevalence rate of autism spectrum disorder (ASD) and predictive value of an observational (ADOS)-and questionnaire-based screening instrument were assessed. Complete data was available for 128 children. The prevalence rate for clinical ASD was 10.9%, which is clearly higher than in the general population. This prevalence rate is presumably more accurate than in previous studies that examined children with NF1 with an ASD presumption or solely based on screening instruments. The combined observational- and screening based classifications demonstrated the highest positive predictive value for DSM-IV diagnosis, highlighting the importance of using both instruments in children with NF1.
在对 1 型神经纤维瘤病(NF1)患儿的非选择性样本中,评估了自闭症谱系障碍(ASD)的患病率以及基于观察(ADOS)和问卷的筛查工具的预测值。共有 128 名儿童的完整数据可用。临床 ASD 的患病率为 10.9%,明显高于普通人群。这一患病率可能比以前研究 NF1 患儿伴 ASD 假设或仅基于筛查工具的研究更为准确。基于观察和筛查的联合分类对 DSM-IV 诊断具有最高的阳性预测值,突出了在 NF1 患儿中同时使用两种工具的重要性。